Controlling CAR-T: How scientists plan to make the engineered T cell therapy safer, and work for more cancers

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it

Date : 2018-07-28T10:22:00.000Z
Source : http://esciencenews.com/node/1539677

관련뉴스

  1. The Curative Potential of CAR-T Cell Therapy in Mantle Cell Lymphoma Though it is still being tested in clinical trials, CAR-T cell therapy can offer hope for patients with mantle cell lymphoma whose disease relapsed. BY Andre Goy, M.D., M.S. PUBLISHED July 26, 2018 Chimeric antigen receptor (CAR)-T cell therapy is … Date : 2018-07-26T15:40:00.000Z Source : https://www.curetoday.com/cure-tv/the-curative-potential-of-car-t-cell-therapy-in-mantle-cell-lymphoma...

  2. CAR-T therapy works for some blood cancers, but can we make it work for brain tumours? T-cells (red) attacking cancer cells (white). Credit: Meletios Verras/Shutterstock.com A powerful new anti-cancer therapy, called CAR-T, has shown great promise in treating blood cancers. Last year, the Food and Drug Administration approved the treatment … Date : 2018-07-26T15:42:00.000Z Source : https://medicalxpress.com/news/2018-07-car-t-therapy-blood-cancers-brain.html...

  3. CAR T Cell Therapy market size, share and Forecast 2026: Leading players Bellicum Pharmaceuticals, Inc., Celgene Corporation, Sorrento Therapeutics, According to Global CAR T Cell Therapy Industry Report, 2018-2026, released by Credence Research, it is projected that the demand size of CAR T Cell Therapy will reach USD xx 2025 The report presents analyze complete analytics for the US, Canada, Japan … Date : 2018-07-27T09:29:00.000Z Source : http://www.tampabayreview.com/news/business/car-t-cell-therapy-market-size-share-forecast-2026-leading-players-bellicum-pharmaceuticals-inc-celgene-corporation-sorrento-therapeutics/14108/...

  4. Global CAR T-Cell Therapy for Multiple Myeloma Market 2018 – Juno Therapeutics, Kite Pharma CAR T-Cell Therapy for Multiple Myeloma Market – Global Industry Analysis, Size, Share, Growth, Trends, History and Forecast 2025 by Manufacturers, Types and Application A recent study titled Global CAR T-Cell Therapy for Multiple Myeloma Market 2018 … Date : 2018-07-20T15:47:00.000Z Source : https://www.cmo.com.au/mediareleases/32335/global-car-t-cell-therapy-for-multiple-myeloma/...

  5. CAR-T Cell Therapy Market, 2018-2024 – Landmark Approvals of CAR-T Cell Therapies by the U.S. FDA and the EMA The “Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends” report has been added to ResearchAndMarkets.com’s offering. CAR-T cell therapy has swept the biotech industry by … (본문 전체 9/7/2018 9:15 PM)...

  6. Current Research & Developments Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Highlight the ongoing clinical and non-clinical advancements in the field of CAR T-cell therapy. – Access the side effects, disadvantages and limitations of existing CAR T-cell technologies. – Examine the current marketed drugs, including development … Date : 2018-07-30T15:26:00.000Z Source : https://www.finanzen.ch/nachrichten/aktien/Current-Research-&-Developments-Status-of-Chimeric-Antigen-Receptor-CAR-T-Cell-Therapy-1027412304...

  7. CAR T-cell therapy ‘quite promising’ for glioblastoma Chimeric antigen receptor T-cell therapy may overcome some of the obstacles associated with systemic therapy for patients with glioblastoma, according to a review published in Neuro-Oncology. Although progress with chimeric antigen receptor (CAR) T-cell … Date : 2018-07-17T14:08:00.000Z Source : https://www.healio.com/hematology-oncology/neuro-oncology/news/online/%7B66c3e2bc-9965-45f7-8d5b-4cf21f380777%7D/car-t-cell-therapy-quite-promising-for-glioblastoma...

  8. Vertex Pharmaceuticals : Nonprofit accelerates stem cell-based Parkinson’s therapy work July 16–Seeking to speed its stem cell-based Parkinson’s therapy to patients, a San Diego nonprofit is moving out of a lab where it has incubated for the last several years. Summit for Stem Cell, an alliance of patients, scientists, doctors and supporters … Date : 2018-07-17T01:17:00.000Z Source : http://www.4-traders.com/VERTEX-PHARMACEUTICALS-11321/news/Vertex-Pharmaceuticals-Nonprofit-accelerates-stem-cell-based-Parkinson-s-therapy-work-26938536/...

  9. Celyad’s Donor Cell CAR-T Therapy Gets Closer to the Clinic Celyad has received FDA approval to start clinical trials for its CAR-T cell therapy, which is engineered to avoid side effects associated with using donor cells for this kind of treatment. The Belgian biotech has been cleared to test its CAR-T cell … Date : 2018-07-24T08:00:00.000Z Source : https://labiotech.eu/medical/celyad-car-t-therapy-clinic/...

  10. Microsite case study They say the best things often come in small packages. Think about it: jewelry, Snapchats, books, the keys to a brand new car … all of these things support this notion. What Is a Microsite? A microsite is an individual web page or small cluster of web pages that act as a separate entity for a ... 추가내용...

  11. CAR-T cell therapy used as treatment for specific types of blood cancer DEAR MAYO CLINIC: What is chimeric antigen receptor T cell (CAR-T cell) therapy? How does it work to treat cancer, and who’s a good candidate for it? ANSWER: CAR-T cell therapy uses white blood cells, called T cells, to fight cancer. It’s approved by … (본문 전체 12/6/2018 3:05 AM)...

  12. Trial to assess feasibility, safety of CAR T-cell therapy for relapsed pediatric central nervous system tumors A clinical trial is underway to examine the role of chimeric antigen receptor T-cell therapy for children and young adults with relapsed or refractory HER-2-positive central nervous system tumors. “[Although] survival rates have improved for pediatric … Date : 2018-07-20T20:13:00.000Z Source : https://www.healio.com/hematology-oncology/pediatric-oncology/news/online/%7B44476930-4812-4055-b018-a13f80b607af%7D/trial-to-assess-feasibility-safety-of-car-t-cell-therapy-for-relapsed-pediatric-central-nervous-system-tumors...

  13. Dr. Maloney Discusses Updates With CAR T-Cell Therapy in NHL David G. Maloney, MD, PhD, professor of medicine, Division of Oncology, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Research Center, discusses updates with chimeric antigen receptor (CAR) T-cell therapy in non-Hodgkin … Date : 2018-07-18T21:31:00.000Z Source : https://www.onclive.com/conference-coverage/pplc-2018/dr-maloney-discusses-updates-with-car-tcell-therapy-in-nhl...

  14. CAR T-cell therapy: What you need to know Chimeric antigen receptor T-cell therapy, also known as CAR T-cell therapy, is approved for two indications — relapsed or refractory large B-cell lymphoma and B-cell acute lymphoblastic leukemia — and is currently being investigated for more cancer types. (본문 전체 8/4/2018 8:45 AM)...

  15. CAR-T cell therapy market is expanding at a CAGR of 51.1% from 2018 to 2026: Credence Research Inc. The latest market report published by Credence Research, Inc. “CAR-T Cell Therapy Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global CAR-T cell therapy market was valued at US$ 72.0 Mn in 2017 expanding at a CAGR … (본문 전체 8/7/2018 7:53 PM)...

  16. CAR T Cell Therapy Market is expected to grow with a CAGR of 50% from 2018-2028. CAR T Cell Therapy Market, anticipate that it will grow at with a CAGR of almost 50% over the period of 2018-2028. Renub Research latest study report “CAR T Cell Therapy Market Global Forecast by Regions (North America, Europe, Asia Pacific, Latin … (본문 전체 9/11/2018 6:24 AM)...

  17. Latest trends in the CAR T-cell therapy market and valuable opportunities for key players The CAR T-cell therapy market is driven by factors such as rising prevalence of cancer, growing research in the immune-oncology, and massive funding from government health institution and pharma giants in CAR-T cell therapy development. The diagnosis of … (본문 전체 9/13/2018 5:28 PM)...

  18. HRC fellowship recognises potential in CAR T-Cell therapy The Malaghan Institutes ground-breaking CAR T-cell therapy programme has received a significant boost from the Health Research Council (HRC) as part of its 2019 Career Development Awards.The Malaghan Institute’s ground-breaking CAR T-cell therapy … (본문 전체 11/20/2018 7:10 AM)...

  19. CAR T Cell Therapy Market 2018-2028 – Global Forecast by Regions, Targeted Antigens, Clinical Trials/Study, Companies – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “CAR T Cell Therapy Market Global Forecast by Regions, Targeted Antigens, Clinical Trials/Study, Companies, and Celgene Corporation” company profile has been added to ResearchAndMarkets.com’s offering. CAR T Cell therapy market … (본문 전체 8/25/2018 11:27 AM)...

  20. Global CAR T Cell Therapy Market is forecasted to be growing at 53% till 2025: Sheer Analytics and Insights The global CAR T Cell therapy market in terms of revenue is expected to go rapidly in terms of revenue generation by 2025 at a CAGR of 53% from 2018 to 2025 as per new market research titled Global CAR T cell therapy market (By Targeted Antigen – HER1 … (본문 전체 9/11/2018 5:35 PM)...

Leave a Comment